Back to Journals » Drug Design, Development and Therapy » Volume 9

Original Research

Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer

         
Total article views   Abstract views HTML views PDF downloads Totals
9,268 Dovepress* 6,557 1,500+ 1,325 8,057
PubMed Central* 0 1,211 380 1,211
Totals 6,557 2,711 1,705 9,268
*Since 8 June 2015
+Since July 2016

View citations on PubMed Central and Google Scholar